These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9023329)

  • 1. Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ET(A) and ET(B) receptors.
    Maguire JJ; Kuc RE; Davenport AP
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1102-8. PubMed ID: 9023329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor subtypes and their functional relevance in human small coronary arteries.
    Pierre LN; Davenport AP
    Br J Pharmacol; 1998 Jun; 124(3):499-506. PubMed ID: 9647474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor expression and pharmacology in human saphenous vein graft.
    Maguire JJ; Davenport AP
    Br J Pharmacol; 1999 Jan; 126(2):443-50. PubMed ID: 10077237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETA receptor antagonists inhibit intimal smooth muscle cell proliferation in human vessels.
    Maguire JJ; Yu JC; Davenport AP
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():184S-188S. PubMed ID: 12193082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
    Nishikibe M; Ohta H; Okada M; Ishikawa K; Hayama T; Fukuroda T; Noguchi K; Saito M; Kanoh T; Ozaki S; Kamei T; Hara K; William D; Kivlighn S; Krause S; Gabel R; Zingaro G; Nolan N; O'Brien J; Clayton F; Lynch J; Pettibone D; Siegl P
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1262-70. PubMed ID: 10336515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.
    Maguire JJ; Kuc RE; Davenport AP
    Br J Pharmacol; 2001 Nov; 134(6):1360-6. PubMed ID: 11704658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myricerone caffeoyl ester (50-235) is a non-peptide antagonist selective for human ETA receptors.
    Maguire JJ; Bacon CR; Fujimoto M; Davenport AP
    J Hypertens; 1994 Jun; 12(6):675-80. PubMed ID: 7963492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of ZD1611, a novel, orally active endothelin ETA receptor antagonist.
    Wilson C; Hunt SJ; Tang E; Wright N; Kelly E; Palmer S; Heys C; Mellor S; James R; Bialecki R
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1085-91. PubMed ID: 10454481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD156707: a potent antagonist of endothelin-1 in human diseased coronary arteries and vein grafts.
    Maguire JJ; Davenport AP
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S239-40. PubMed ID: 9595448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
    Davenport AP; Kuc RE; Ashby MJ; Patt WC; Doherty AM
    Br J Pharmacol; 1998 Jan; 123(2):223-30. PubMed ID: 9489609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonists.
    Patt WC; Edmunds JJ; Repine JT; Berryman KA; Reisdorph BR; Lee C; Plummer MS; Shahripour A; Haleen SJ; Keiser JA; Flynn MA; Welch KM; Reynolds EE; Rubin R; Tobias B; Hallak H; Doherty AM
    J Med Chem; 1997 Mar; 40(7):1063-74. PubMed ID: 9089328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.
    Ohlstein EH; Nambi P; Hay DW; Gellai M; Brooks DP; Luengo J; Xiang JN; Elliott JD
    J Pharmacol Exp Ther; 1998 Aug; 286(2):650-6. PubMed ID: 9694916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of a novel series of orally active nonpeptide ETA and ETA/B endothelin receptor-selective antagonists.
    Doherty AM; Patt WC; Repine J; Edmunds JJ; Berryman KA; Reisdorph BR; Walker DM; Haleen SJ; Keiser JA; Flynn MA
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S358-61. PubMed ID: 8587414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein.
    Claing A; Shbaklo H; Plante M; Bkaily G; D'Orléans-Juste P
    Br J Pharmacol; 2002 Jan; 135(2):433-43. PubMed ID: 11815379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and binding characterization of endothelin receptors in human bronchus: evidence for a novel endothelin B receptor subtype?
    Hay DW; Luttmann MA; Pullen MA; Nambi P
    J Pharmacol Exp Ther; 1998 Feb; 284(2):669-77. PubMed ID: 9454813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpeptide endothelin receptor antagonists. VII: Binding characteristics of [3H]SB 209670, a novel nonpeptide antagonist of endothelin receptors.
    Nambi P; Pullen M; Wu HL; Lee D; Saunders D; Heys R; Aiyar N; Leber J; Elliott J; Brooks D; Ohlstein E; Ruffolo R
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1567-71. PubMed ID: 8667224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins.
    Haug C; Schmid-Kotsas A; Zorn U; Schuett S; Gross HJ; Gruenert A; Bachem MG
    J Mol Cell Cardiol; 2001 Sep; 33(9):1701-12. PubMed ID: 11549348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of endothelin-induced venoconstriction in isolated guinea pig mesentery.
    Johnson RJ; Fink GD; Galligan JJ
    J Pharmacol Exp Ther; 1999 May; 289(2):762-7. PubMed ID: 10215650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of T-0201, a highly potent and orally active endothelin receptor antagonist.
    Hoshino T; Yamauchi R; Kikkawa K; Yabana H; Murata S
    J Pharmacol Exp Ther; 1998 Aug; 286(2):643-9. PubMed ID: 9694915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia.
    Patel TR; Galbraith S; Graham DI; Hallak H; Doherty AM; McCulloch J
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):950-8. PubMed ID: 8784239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.